Skip to main content
OpenTrials

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

99 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Recruiting

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

NCT06445972

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 8905) Los Angeles, California, United States
  • Norton Cancer Institute - Downtown ( Site 8900) Louisville, Kentucky, United States
  • The Cancer and Hematology Centers ( Site 8912) Grand Rapids, Michigan, United States
View all 47 locations
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 31 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

NCT06469944

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 6905) Los Angeles, California, United States
  • Norton Hospital-Norton Cancer Institute - Downtown ( Site 6900) Louisville, Kentucky, United States
  • The Cancer and Hematology Centers ( Site 6912) Grand Rapids, Michigan, United States
View all 51 locations
View Trial Details
Recruiting

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816

Conditions
Adnexal Diseases, Advanced Solid Tumours, Breast Diseases, +53 more
Locations
  • Guy's Hopsital London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details

Related conditions